1. WHO. WHO World Malaria Report 2020. Malaria report 2020. 2020.
2. Rowe AK, Rowe SY, Snow RW, Korenromp EL, Armstrong Schellenberg JRM, Stein C, et al. The burden of malaria mortality among African children in the year 2000. International Journal of Epidemiology. 2006.
3. Baba E, Hamade P, Kivumbi H, Marasciulo M, Maxwell K, Moroso D, et al. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study. Lancet. 2020;
4. Witkowski B, Berry A, Benoit-Vical F. Resistance to antimalarial compounds: Methods and applications. Drug Resist Updat. 2009;
5. Burns AL, Sleebs BE, Siddiqui G, De Paoli AE, Anderson D, Liffner B, et al. Retargeting azithromycin analogues to have dual-modality antimalarial activity. BMC Biol [Internet]. 2020 Sep 29 [cited 2021 May 28];18(1). Available from: https://pubmed.ncbi.nlm.nih.gov/32993629/
6. Oldenburg CE, Amza A, Cooley G, Kadri B, Nassirou B, Arnold BF, et al. Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: A sub-study of a cluster randomized trial. Malar J. 2019;
7. Keenan JD, Bailey RL, West SK, Arzika AM, Hart J, Weaver J, et al. Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa. N Engl J Med. 2018;
8. Arzika AM, Maliki R, Boubacar N, Kane S, Cotter SY, Lebas E, et al. Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial. PLoS Med. 2019;
9. FY 2020 Burkina Faso Malaria Operational Plan [Internet]. [cited 2021 May 13]. Available from: www.pmi.gov
10. De M, Sante LA, Faso B. Avec l’appui de l’UNICEF.
11. Otte Im Kampe E, Müller O, Sie A, Becher H. Seasonal and temporal trends in all-cause and malaria mortality in rural Burkina Faso, 1998-2007. Malar J. 2015;
12. States Agency for International Development U. PMI VECTORLINK Burkina Faso Entomological Monitoring Annual Report, January—December 2019. 2019.
13. Tourre YM, Vignolles C, Viel C, Faruque FS, Malone JB. Malaria in Burkina Faso (West Africa) during the twenty-first century. [cited 2021 Jun 2]; Available from: https://doi.org/10.1007/s10661-019-7410-7
14. Sié A, Louis V, Gbangou A, Müller O, Niamba L, Stieglbauer G, et al. The Health and Demographic Surveillance System (HDSS) in Nouna, Burkina Faso, 1993–2007. Glob Health Action. 2010;
15. Basilion E V., Kilima PM, Mecaskey JW. Simplification and improvement of height-based azithromycin treatment for paediatric trachoma. Trans R Soc Trop Med Hyg. 2005;
16. Sié A, Dah C, Bountogo M, Ouattara M, Nebie E, Coulibaly B, et al. Adverse events and clinic visits following a single dose of oral azithromycin among preschool children: A randomized placebo-controlled trial. Am J Trop Med Hyg. 2021;
17. Oldenburg CE, Arzika AM, Maliki R, Kane MS, Lebas E, Ray KJ, et al. Safety of azithromycin in infants under six months of age in Niger: A community randomized trial. PLoS Negl Trop Dis [Internet]. 2018 Nov 1 [cited 2021 May 27];12(11). Available from: https://pubmed.ncbi.nlm.nih.gov/30419040/
18. Ayele B, Gebre T, House JI, Zhou Z, McCulloch CE, Porco TC, et al. Adverse events after mass azithromycin treatments for trachoma in Ethiopia. Am J Trop Med Hyg [Internet]. 2011 Aug [cited 2021 May 27];85(2):291–4. Available from: /pmc/articles/PMC3144828/
19. Phiri MD, Cairns M, Zongo I, Nikiema F, Diarra M, Yerbanga RS, et al. The Duration of Protection from Azithromycin Against Malaria, Acute Respiratory, Gastrointestinal, and Skin Infections When Given Alongside Seasonal Malaria Chemoprevention: Secondary Analyses of Data from a Clinical Trial in Houndé, Burkina Faso, and Bou. Clin Infect Dis. 2021;
20. WHO. Burkina Faso World Malaria Report [Internet]. 2016 [cited 2021 May 14]. Available from: https://www.who.int/malaria/publications/country-profiles/2016/profile_bfa_en.pdf?ua=1
21. Schachterle SE, Mtove G, Levens JP, Clemens E, Shi L, Raj A, et al. Short-term malaria reduction by single-dose azithromycin during mass drug administration for trachoma, Tanzania. Emerg Infect Dis. 2014;
22. Chandramohan D, Dicko A, Zongo I, Sagara I, Cairns M, Kuepfer I, et al. Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention. N Engl J Med. 2019;
23. Diallo A, Sié A, Sirima S, Sylla K, Ndiaye M, Bountogo M, et al. An epidemiological study to assess Plasmodium falciparum parasite prevalence and malaria control measures in Burkina Faso and Senegal. Malar J. 2017;
24. Gaynor BD, Amza A, Kadri B, Nassirou B, Lawan O, Maman L, et al. Impact of mass azithromycin distribution on malaria parasitemia during the low-transmission season in Niger: A cluster-randomized trial. Am J Trop Med Hyg [Internet]. 2014 [cited 2021 May 27];90(5):846–51. Available from: https://pubmed.ncbi.nlm.nih.gov/24615132/
25. Porco TC, Gebre T, Ayele B, House J, Keenan J, Zhou Z, et al. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: A randomized trial. JAMA - J Am Med Assoc [Internet]. 2009 Sep 2 [cited 2021 May 27];302(9):962–8. Available from: https://jamanetwork.com/
26. O’Brien KS, Cotter SY, Amza A, Kadri B, Nassirou B, Stoller NE, et al. Mass azithromycin and malaria parasitemia in Niger: Results from a community-randomized trial. Am J Trop Med Hyg [Internet]. 2017 [cited 2021 Jun 2];97(3):696–701. Available from: https://pubmed.ncbi.nlm.nih.gov/28722569/
27. Bloch EM, Munoz B, Mrango Z, Weaver J, Mboera LEG, Lietman TM, et al. The impact on malaria of biannual treatment with azithromycin in children age less than 5 years: A prospective study. Malar J [Internet]. 2019 Aug 23 [cited 2021 Jun 2];18(1). Available from: https://pubmed.ncbi.nlm.nih.gov/31443654/
28. Hart JD, Samikwa L, Sikina F, Kalua K, Keenan JD, Lietman TM, et al. Effects of Biannual Azithromycin Mass Drug Administration on Malaria in Malawian Children: A Cluster-Randomized Trial. Am J Trop Med Hyg [Internet]. 2020 Sep 1 [cited 2021 Jun 2];103(3):1329–34. Available from: https://pubmed.ncbi.nlm.nih.gov/32342841/
29. Gendrin M, Yerbanga RS, Ouedraogo JB, Lefèvre T, Cohuet A, Christophides GK. Differential effects of azithromycin, doxycycline, and cotrimoxazole in ingested blood on the vectorial capacity of malaria mosquitoes. Open Forum Infect Dis. 2016;
30. Tiono AB, Ouédraogo A, Diarra A, Coulibaly S, Soulama I, Konaté AT, et al. Lessons learned from the use of HRP-2 based rapid diagnostic test in community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso. Malar J. 2014;
31. Watson OJ, Sumner KM, Janko M, Goel V, Winskill P, Slater HC, et al. False-negative malaria rapid diagnostic test results and their impact on community-based malaria surveys in sub-Saharan Africa. BMJ Glob Heal. 2019;
32. Plucinski MM, Dimbu PR, Fortes F, Murphy SC, Smith NT, Cruz KR, et al. Malaria parasite density in individuals with different rapid diagnostic test results and concentrations of HRP2 antigen. Am J Trop Med Hyg. 2019;
33. Rapp RP. Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: Enhanced tissue activity and minimal drug interactions. Annals of Pharmacotherapy. 1998.